JP2016513736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513736A5 JP2016513736A5 JP2016502836A JP2016502836A JP2016513736A5 JP 2016513736 A5 JP2016513736 A5 JP 2016513736A5 JP 2016502836 A JP2016502836 A JP 2016502836A JP 2016502836 A JP2016502836 A JP 2016502836A JP 2016513736 A5 JP2016513736 A5 JP 2016513736A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pharmaceutically acceptable
- acceptable salt
- naloxone
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/842,543 US20140271788A1 (en) | 2013-03-15 | 2013-03-15 | Sublingual and buccal film compositions |
| US13/842,543 | 2013-03-15 | ||
| US14/196,082 | 2014-03-04 | ||
| US14/196,082 US9511033B2 (en) | 2013-03-15 | 2014-03-04 | Sublingual and buccal film compositions |
| PCT/US2014/028568 WO2014144241A1 (en) | 2013-03-15 | 2014-03-14 | Sublingual and buccal film compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018225191A Division JP2019048882A (ja) | 2013-03-15 | 2018-11-30 | 舌下及び頬用フィルム組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016513736A JP2016513736A (ja) | 2016-05-16 |
| JP2016513736A5 true JP2016513736A5 (cg-RX-API-DMAC7.html) | 2018-07-05 |
| JP6448096B2 JP6448096B2 (ja) | 2019-01-09 |
Family
ID=51528033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502836A Active JP6448096B2 (ja) | 2013-03-15 | 2014-03-14 | 舌下及び頬用フィルム組成物 |
| JP2018225191A Abandoned JP2019048882A (ja) | 2013-03-15 | 2018-11-30 | 舌下及び頬用フィルム組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018225191A Abandoned JP2019048882A (ja) | 2013-03-15 | 2018-11-30 | 舌下及び頬用フィルム組成物 |
Country Status (15)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140271788A1 (en) * | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| WO2016071767A1 (en) | 2014-11-07 | 2016-05-12 | Indivior Uk Limited | Buprenorphine dosing regimens |
| US20160175296A1 (en) * | 2014-12-23 | 2016-06-23 | Arx, Llc | Method of producing uniform buprenorphine-containing formulations |
| JPWO2016163403A1 (ja) * | 2015-04-07 | 2018-02-01 | ニプロ株式会社 | 経口フィルム製剤 |
| DK3411031T3 (da) | 2016-02-04 | 2024-10-21 | Cindome Pharma Inc | Deutererede domperidonpræparater og fremgangsmåder til terapi af lidelser |
| US11738036B2 (en) | 2016-05-28 | 2023-08-29 | Rajiv Gandhi Centre For Biotechnology, An Autonomous Institute Under The Department Of Biotechnology, Government Of India | Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma |
| IL266537B2 (en) | 2016-11-15 | 2023-12-01 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| MX2019007923A (es) | 2016-12-31 | 2019-09-10 | Bioxcel Therapeutics Inc | Uso de dexmedetomidina sublingual para el tratamiento de la agitacion. |
| GB201709141D0 (en) | 2017-06-08 | 2017-07-26 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| US10646484B2 (en) | 2017-06-16 | 2020-05-12 | Indivior Uk Limited | Methods to treat opioid use disorder |
| US12478612B2 (en) | 2017-06-30 | 2025-11-25 | Cindome Pharma, Inc. | Deuterated domperidone compositions, methods, and preparation |
| KR20240125702A (ko) | 2017-06-30 | 2024-08-19 | 신돔 파마, 인크. | 중수소화 돔페리돈 조성물, 방법, 및 제조 |
| EP3473246A1 (en) | 2017-10-19 | 2019-04-24 | Capsugel Belgium NV | Immediate release abuse deterrent formulations |
| GB201808462D0 (en) * | 2018-05-23 | 2018-07-11 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| JPWO2019240212A1 (ja) | 2018-06-14 | 2021-06-24 | 株式会社カネカ | 薬学的活性成分を含む製剤 |
| PT3813802T (pt) | 2018-06-27 | 2025-01-15 | Arx Llc | Formulações de películas contendo dexmedetomidina e métodos de produção das mesmas |
| WO2020006073A1 (en) * | 2018-06-28 | 2020-01-02 | Arx, Llc | Dispensing method for producing dissolvable unit dose film constructs |
| GB201819978D0 (en) * | 2018-12-11 | 2019-01-23 | Univ Strathclyde | Oral thin films |
| JP7287032B2 (ja) | 2019-03-20 | 2023-06-06 | 株式会社リコー | シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法 |
| KR20220049526A (ko) | 2019-07-19 | 2022-04-21 | 바이오엑셀 테라퓨틱스 인코포레이티드 | 비-진정성 덱스메데토미딘 치료 양생법 |
| US11806320B2 (en) * | 2020-02-19 | 2023-11-07 | Endo Ventures Limited | Isoproterenol compositions and methods |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| WO2025147530A1 (en) * | 2024-01-05 | 2025-07-10 | Taho Pharmaceuticals Ltd. | Naloxone buccal film product and uses thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3493657A (en) | 1961-03-14 | 1970-02-03 | Mozes Juda Lewenstein | Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine |
| US4457933A (en) | 1980-01-24 | 1984-07-03 | Bristol-Myers Company | Prevention of analgesic abuse |
| US4366159A (en) | 1981-09-08 | 1982-12-28 | Michael Richard Magruder | Nalbuphine-narcotic analgesic composition and method of producing analgesia |
| GB8332556D0 (en) | 1983-12-06 | 1984-01-11 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
| US5225417A (en) | 1992-01-21 | 1993-07-06 | G. D. Searle & Co. | Opioid agonist compounds |
| US5223507A (en) | 1992-01-21 | 1993-06-29 | G. D. Searle & Co. | Method of using opioid compounds as delta opioid selective agonist analgesics |
| GB9202464D0 (en) | 1992-02-05 | 1992-03-18 | Danbiosyst Uk | Composition for nasal administration |
| EP0782445B1 (en) | 1994-09-19 | 2002-03-13 | Dupont Pharmaceuticals Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| US5866154A (en) * | 1994-10-07 | 1999-02-02 | The Dupont Merck Pharmaceutical Company | Stabilized naloxone formulations |
| AT403162B (de) | 1995-10-11 | 1997-11-25 | Nycomed Austria Gmbh | Neue kristallform von morphin-6-glucuronid |
| DE19602959A1 (de) | 1995-12-20 | 1997-07-31 | Nycomed Arzneimittel Gmbh | Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung |
| DK0914097T3 (da) | 1996-03-12 | 2002-04-29 | Alza Corp | Sammensætning og doseringsform omfattende opioid antagonist |
| WO1998035679A1 (de) | 1997-02-14 | 1998-08-20 | Gödecke Aktiengesellschaft | Stabilisierung von naloxonhydrochlorid |
| ES2217563T3 (es) | 1997-07-11 | 2004-11-01 | Toray Industries, Inc. | Compuestos medicinales estables que contienen derivados de 4,5-epoximorfinado. |
| ATE210983T1 (de) | 1997-11-03 | 2002-01-15 | Stada Arzneimittel Ag | Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum |
| IT1302682B1 (it) | 1998-10-16 | 2000-09-29 | Formenti Farmaceutici Spa | Composizioni farmaceutiche orali contenenti buprenorfina |
| US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US20140271788A1 (en) * | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US7666337B2 (en) | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US20110033542A1 (en) * | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| US8017150B2 (en) | 2002-04-11 | 2011-09-13 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| CA2530843A1 (en) * | 2003-07-01 | 2005-01-20 | Todd Maibach | Film comprising therapeutic agents |
| WO2005117838A1 (en) * | 2004-06-02 | 2005-12-15 | Galephar M/F | Stable oral pharmaceutical compositions of buprenorphine and derivatives |
| US20060046962A1 (en) * | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
| US7666442B2 (en) * | 2004-08-31 | 2010-02-23 | Tracie Martyn International, Llc | Topical compositions comprising benfotiamine and pyridoxamine |
| JP2007304673A (ja) | 2006-05-09 | 2007-11-22 | Kyocera Mita Corp | 監視装置及び監視システム並びに監視プログラム |
| US8475832B2 (en) * | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
-
2013
- 2013-03-15 US US13/842,543 patent/US20140271788A1/en not_active Abandoned
-
2014
- 2014-03-04 US US14/196,082 patent/US9511033B2/en active Active
- 2014-03-14 CA CA2906773A patent/CA2906773C/en active Active
- 2014-03-14 EP EP14721650.1A patent/EP2968121B1/en active Active
- 2014-03-14 JP JP2016502836A patent/JP6448096B2/ja active Active
- 2014-03-14 WO PCT/US2014/028568 patent/WO2014144241A1/en not_active Ceased
- 2014-03-14 RU RU2015143647A patent/RU2015143647A/ru not_active Application Discontinuation
- 2014-03-14 MY MYPI2015703198A patent/MY181159A/en unknown
- 2014-03-14 BR BR112015023725A patent/BR112015023725A2/pt not_active Application Discontinuation
- 2014-03-14 MX MX2015013184A patent/MX2015013184A/es unknown
- 2014-03-14 CN CN201480027179.8A patent/CN105491997B/zh active Active
- 2014-03-14 DK DK14721650.1T patent/DK2968121T3/en active
- 2014-03-14 AU AU2014227693A patent/AU2014227693B2/en active Active
- 2014-03-14 KR KR1020157028424A patent/KR20160029730A/ko not_active Withdrawn
-
2015
- 2015-09-10 IL IL241441A patent/IL241441B/en active IP Right Grant
- 2015-10-14 ZA ZA2015/07685A patent/ZA201507685B/en unknown
-
2016
- 2016-12-05 US US15/369,101 patent/US20170296482A1/en not_active Abandoned
-
2018
- 2018-10-09 US US16/155,100 patent/US20190038570A1/en not_active Abandoned
- 2018-11-30 JP JP2018225191A patent/JP2019048882A/ja not_active Abandoned
-
2019
- 2019-12-06 US US16/705,422 patent/US20200315984A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016513736A5 (cg-RX-API-DMAC7.html) | ||
| JP5594925B2 (ja) | 活性物質の送達のための急速に溶解するフィルム | |
| JP2006516648A5 (cg-RX-API-DMAC7.html) | ||
| US20030096012A1 (en) | Film-forming powder, compositions containing it, methods for their preparation and their uses | |
| JP2013501718A5 (cg-RX-API-DMAC7.html) | ||
| ES2199982T3 (es) | Tableta recubierta de paracetamol y domperidona. | |
| CA2453117A1 (en) | Oral dosage forms comprising a benzimidazole and buffer | |
| AR073851A1 (es) | Forma de dosificacion intraoral de multiples porciones y uso de esta. sistema de suministro. formulacion | |
| JP2005510538A5 (cg-RX-API-DMAC7.html) | ||
| JP2003520223A5 (cg-RX-API-DMAC7.html) | ||
| CA2467611A1 (en) | Azithromycin dosage forms with reduced side effects | |
| RU2015143647A (ru) | Пленочные композиции для сублингвального и буккального введения | |
| JP2013501717A5 (cg-RX-API-DMAC7.html) | ||
| JP2013121983A5 (cg-RX-API-DMAC7.html) | ||
| ES2706481T3 (es) | Forma de dosificación en película oral humectable de forma instantánea sin tensioactivo o polialcohol | |
| JPS62123133A (ja) | 制御された作用の長い調合製剤用の乾燥担体の調整方法及びその乾燥担体 | |
| JPH03501737A (ja) | 低温融解性の成形可能な医薬品賦形剤及びこれを用いた投与剤形 | |
| JP2013523677A5 (cg-RX-API-DMAC7.html) | ||
| Puratchikody et al. | Buccal drug delivery: past, present and future-a review | |
| JP2016175936A5 (cg-RX-API-DMAC7.html) | ||
| CA3082201C (en) | Pouch-type orally dissolving films with high active ingredient concentration | |
| MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
| JP2011518842A5 (cg-RX-API-DMAC7.html) | ||
| WO2005118166A3 (en) | Pharmaceutical composition containing irbesartan | |
| JP2016514680A5 (cg-RX-API-DMAC7.html) |